187 related articles for article (PubMed ID: 9887220)
1. Determination of low-molecular-weight heparins and their binding to protamine and a protamine analog using polyion-sensitive membrane electrodes.
Ramamurthy N; Baliga N; Wakefield TW; Andrews PC; Yang VC; Meyerhoff ME
Anal Biochem; 1999 Jan; 266(1):116-24. PubMed ID: 9887220
[TBL] [Abstract][Full Text] [Related]
2. Enhanced sensitivity electrochemical assay of low-molecular-weight heparins using rotating polyion-sensitive membrane electrodes.
Qin W; Zhang W; Xiao KP; Meyerhoff ME
Anal Bioanal Chem; 2003 Nov; 377(5):929-36. PubMed ID: 12879195
[TBL] [Abstract][Full Text] [Related]
3. Polyion-sensitive membrane-based electrodes for heparin-binding foldamer analysis.
Kelly C; Khaja S; Vena A; Yu A; Esson JM
Anal Chim Acta; 2010 Nov; 681(1-2):1-7. PubMed ID: 21035596
[TBL] [Abstract][Full Text] [Related]
4. A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation.
Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Tejwani S; Hulin MS; Stanley JC
J Surg Res; 1996 Jun; 63(1):280-6. PubMed ID: 8661211
[TBL] [Abstract][Full Text] [Related]
5. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
[TBL] [Abstract][Full Text] [Related]
6. Protamine-sensitive polymer membrane electrode: characterization and bioanalytical applications.
Yun JH; Meyerhoff ME; Yang VC
Anal Biochem; 1995 Jan; 224(1):212-20. PubMed ID: 7710074
[TBL] [Abstract][Full Text] [Related]
7. Polycation-sensitive membrane electrode for determination of heparin based on controlled release of protamine.
Chen Y; Ding J; Qin W
Analyst; 2012 Apr; 137(8):1944-9. PubMed ID: 22398822
[TBL] [Abstract][Full Text] [Related]
8. A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins.
Patel RP; Narkowicz C; Hutchinson JP; Hilder EF; Jacobson GA
J Pharm Biomed Anal; 2008 Jan; 46(1):30-5. PubMed ID: 18024047
[TBL] [Abstract][Full Text] [Related]
9. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
[TBL] [Abstract][Full Text] [Related]
10. Titrimetric method for determination of O-desulfated heparin in physiological samples using protamine-sensitive membrane electrode as endpoint detector.
Buchanan SA; Kennedy TP; MacArthur RB; Meyerhoff ME
Anal Biochem; 2005 Nov; 346(2):241-5. PubMed ID: 16213460
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
[TBL] [Abstract][Full Text] [Related]
12. Label-free and substrate-free potentiometric aptasensing using polycation-sensitive membrane electrodes.
Ding J; Chen Y; Wang X; Qin W
Anal Chem; 2012 Feb; 84(4):2055-61. PubMed ID: 22263631
[TBL] [Abstract][Full Text] [Related]
13. A moving-part-free protamine-sensitive polymeric membrane electrode for sensitive biomedical analyses.
Wang X; Wang Q; Qin W
Biosens Bioelectron; 2012; 38(1):145-50. PubMed ID: 22672765
[TBL] [Abstract][Full Text] [Related]
14. A simplified screening procedure for determination of total N-NO groups (TNG) and nitrite (NO2-) in commercial low-molecular-weight heparins (LMWH) by selective chemical denitrosation followed by high-sensitivity chemiluminescence detection (NO-analyzer, NOA).
Beretta G; Gelmini F; Merlino M; Furlanetto S; Facino RM
J Pharm Biomed Anal; 2009 Jul; 49(5):1179-84. PubMed ID: 19356877
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity.
Chang LC; Liang JF; Lee HF; Lee LM; Yang VC
AAPS PharmSci; 2001; 3(3):E18. PubMed ID: 11741269
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
17. [Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].
Drozd NN; Tolstenkov AS; Bannikova GE; Miftakhova NT; Lapikova ES; Makarov VA; Varlamov VP
Eksp Klin Farmakol; 2007; 70(6):19-24. PubMed ID: 18318190
[TBL] [Abstract][Full Text] [Related]
18. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection.
Chang LC; Meyerhoff ME; Yang VC
Anal Biochem; 1999 Dec; 276(1):8-12. PubMed ID: 10585738
[TBL] [Abstract][Full Text] [Related]
19. Structural features and bleeding activity of commercial low molecular weight heparins: neutralization by ATP and protamine.
Dietrich CP; Shinjo SK; Moraes FA; Castro RA; Mendes A; Gouvea TC; Nader HB
Semin Thromb Hemost; 1999; 25 Suppl 3():43-50. PubMed ID: 10549715
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
Lin P; Sinha U; Betz A
Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
